(Q53728213)

English

Prediction of Outcome in Diffuse Large Cell Lymphoma by the Major Histocompatibility Complex Class II (HLA-DR, DP, DQ) and Class I (HLA-A, B, C) Phenotype.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

18 May 2018

http://europepmc.org/abstract/MED/27457573

Prediction of Outcome in Diffuse Large Cell Lymphoma by the Major Histocompatibility Complex Class II (HLA-DR, DP, DQ) and Class I (HLA-A, B, C) Phenotype. (English)

1 reference

Europe PubMed Central

18 May 2018

http://europepmc.org/abstract/MED/27457573

author name string

J A Rybski

1

1 reference

Europe PubMed Central

18 May 2018

http://europepmc.org/abstract/MED/27457573

C M Spier

2

1 reference

Europe PubMed Central

18 May 2018

http://europepmc.org/abstract/MED/27457573

T P Miller

3

1 reference

Europe PubMed Central

18 May 2018

http://europepmc.org/abstract/MED/27457573

S M Lippman

4

1 reference

Europe PubMed Central

18 May 2018

http://europepmc.org/abstract/MED/27457573

D L McGee

5

1 reference

Europe PubMed Central

18 May 2018

http://europepmc.org/abstract/MED/27457573

T M Grogan

6

1 reference

Europe PubMed Central

18 May 2018

http://europepmc.org/abstract/MED/27457573

publication date

1 January 1991

1 reference

Europe PubMed Central

18 May 2018

http://europepmc.org/abstract/MED/27457573

Leukemia & Lymphoma

1 reference

Europe PubMed Central

18 May 2018

http://europepmc.org/abstract/MED/27457573

6

1 reference

Europe PubMed Central

18 May 2018

http://europepmc.org/abstract/MED/27457573

1

1 reference

Europe PubMed Central

18 May 2018

http://europepmc.org/abstract/MED/27457573

31-38

1 reference

Europe PubMed Central

18 May 2018

http://europepmc.org/abstract/MED/27457573

HLA-DR (Ia) immune phenotype predicts outcome for patients with diffuse large cell lymphoma

1 reference

https://api.crossref.org/works/10.3109%2F10428199109064876

21 January 2018

Role of the major histocompatibility complex class I antigens in tumor growth and metastasis

1 reference

https://api.crossref.org/works/10.3109%2F10428199109064876

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.3109%2F10428199109064876

21 January 2018

B-cell lymphomas of high-grade malignancy frequently lack HLA-DR, -DP and -DQ antigens and associated invariant chain.

1 reference

https://api.crossref.org/works/10.3109%2F10428199109064876

21 January 2018

Markedly decreased expression of class I histocompatibility antigens, protein, and mRNA in human small-cell lung cancer

1 reference

https://api.crossref.org/works/10.3109%2F10428199109064876

21 January 2018

DNA content and MHC class II antigen expression in malignant melanoma: clinical course

1 reference

https://api.crossref.org/works/10.3109%2F10428199109064876

21 January 2018

Melanoma antigens: immunological and biological characterization and clinical significance

1 reference

https://api.crossref.org/works/10.3109%2F10428199109064876

21 January 2018

HLA-DR histocompatibility leukocyte antigens permit cultured human melanoma cells from early but not advanced disease to stimulate autologous lymphocytes

1 reference

https://api.crossref.org/works/10.3109%2F10428199109064876

21 January 2018

Identifiers

10.3109/10428199109064876

1 reference

Europe PubMed Central

18 May 2018

http://europepmc.org/abstract/MED/27457573

1 reference

Europe PubMed Central

18 May 2018

http://europepmc.org/abstract/MED/27457573

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53728213&oldid=914111625"